Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
Acta Pharmacol Sin. 2011 Jan;32(1):108-15. doi: 10.1038/aps.2010.192. Epub 2010 Dec 20.
To prepare a novel formulation of phosphatidylcholine (PC)-bile salts (BS)-mixed micelles (MMs) loaded with silybin (SLB)-PC complex for parenteral applications.
SLB-PC-BS-MMs were prepared using the co-precipitation method. Differential scanning calorimetry (DSC) analysis was used to confirm the formation of the complex and several parameters were optimized to obtain a high quality formulation. The water-solubility, drug loading, particle size, zeta potential, morphology and in vivo properties of the SLB-PC-BS-MMs were determined.
The solubility of SLB in water was increased from 40.83 ± 1.18 μg/mL to 10.14 ± 0.36 mg/mL with a high drug loading (DL) of 14.43% ± 0.44% under optimized conditions. The SLB-PC-BS-MMs were observed by transmission electron microscopy (TEM) and scanning electron microscopy (SEM) and showed spherical shapes. The particle size and zeta potential, as measured by photon correlation spectroscopy (PCS), were about 30 ± 4.8 nm and -39 ± 5.0 mV, respectively. In vivo studies showed that incorporation of the SLB-PC complex into PC-BS-MMs led to a prolonged circulation time of the drug.
This novel formulation appears to be a good candidate for drug substances that exhibit poor solubility for parenteral administration.
制备一种新型的磷脂(PC)-胆汁盐(BS)-混合胶束(MM),负载水飞蓟宾(SLB)-PC 复合物,用于注射应用。
采用共沉淀法制备 SLB-PC-BS-MMs。差示扫描量热法(DSC)分析用于确认复合物的形成,并优化了几个参数以获得高质量的配方。测定了 SLB-PC-BS-MMs 的水溶性、载药量、粒径、Zeta 电位、形态和体内性质。
在优化条件下,SLB 的水溶解度从 40.83 ± 1.18 μg/mL 增加到 10.14 ± 0.36 mg/mL,载药量(DL)高达 14.43% ± 0.44%。透射电子显微镜(TEM)和扫描电子显微镜(SEM)观察到 SLB-PC-BS-MMs 呈球形。光子相关光谱(PCS)测量的粒径和 Zeta 电位分别约为 30 ± 4.8nm 和-39 ± 5.0mV。体内研究表明,将 SLB-PC 复合物掺入 PC-BS-MMs 中可延长药物的循环时间。
这种新型制剂似乎是一种适合用于注射给药的水溶性差的药物的候选药物。